4
Update on MALT lymphomas

https://doi.org/10.1016/j.beha.2004.08.003Get rights and content

Gastric mucosa associated lymphoid tissue (MALT) lymphoma is a histologically distinct tumour derived from MALT acquired as a result of Helicobacter pylori infection. Eradication of H. pylori causes clinical regression of the lymphoma in 75% of cases. In seeking to identify those cases resistant to this therapy, and in the interests of further understanding the biology of MALT lymphoma, genetic alterations of MALT lymphomas have been investigated. Three translocations, t(11;18)(q21;q21), t(1;14)(p22;q32) and t(14;18)(q32;q21) are specifically associated with MALT lymphoma and the genes involved have been identified. T(11;18) results in a chimeric fusion between the API2 and MALT1 genes and is specifically associated with gastric MALT lymphomas that do not respond to eradication of H. pylori. T(1;14) and t(14;18) deregulate BCL10 and MALT1 expression, respectively. These three chromosomal translocations that involve different genes appear to share common oncogenic properties by targeting the same nuclear factor κB (NFκB) oncogenic pathway.

Section snippets

Epidemiology

MALT lymphoma comprises 7–8% of all B-cell lymphomas and at least 50% of primary gastric lymphomas.2., 3. Most cases occur in adults with a median age of 61 years and a slight female predominance, which is more marked in salivary gland MALT lymphoma. There is a higher incidence of gastric MALT lymphoma in north-eastern Italy probably related to a high prevalence of Helicobacter pylori associated gastritis in that region.4 A special sub-type of small intestinal MALT lymphomas, known as

Aetiology

MALT lymphomas only rarely arise from native MALT; they more usually arise from MALT that has been acquired as a result of a chronic inflammatory disorder (see below) at sites normally devoid of MALT, such as the stomach, salivary gland, lung, thyroid and ocular adnexa. MALT lymphomas of the salivary gland and thyroid, organs normally containing no lymphoid tissue, are always preceded by lymphoepithelial (myoepithelial) sialadenitis (LESA)6., 7., 8. usually associated with Sjögren's syndrome

Molecular genetics

A number of genetic alterations have been identified in MALT lymphomas including trisomy 328, p53 mutation/LOH29, and p16 deletion.30 More recently, three specific translocations, t(11;18)(q21;q21)31., 32., t(1;14)(p22;q32)33, and t(14;18)(q32;q21)34., 35. have been recognised in MALT lymphomas. T(11;18)(q21;q21) results in a chimeric fusion between the API2 and MALT1 genes36., 37., 38., whereas t(1;14)(p22;q32) and t(14;18)(q32;q21) cause deregulated expression of BCL1039., 40. and MALT34., 35.

Summary

MALT lymphomas are a subgroup of low-grade B-cell lymphomas that arise from extranodal sites that have accumulated MALT as a result of a chronic inflammatory disorder. Subsequent work clarified the interrelationship between gastric MALT lymphoma and H. pylori resulting in the novel treatment of gastric lymphoma using antibiotics. More recently, three chromosomal translocations have been found to characterise MALT lymphoma, their frequency at least in part depending on the site of origin of the

References (67)

  • M. Du et al.

    The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma

    Blood

    (1995)
  • P. Neumeister et al.

    Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas

    Gastroenterology

    (1997)
  • I.A. Auer et al.

    t(11;18)(q21;q21) is the most common translocation in MALT lymphomas

    Annals of Oncology

    (1997)
  • A.C. Wotherspoon et al.

    Cytogenetic study of B-cell lymphoma of mucosa-associated lymphoid tissue

    Cancer Genetics and Cytogenetics

    (1992)
  • D. Sanchez-Izquierdo et al.

    MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma

    Blood

    (2003)
  • J. Dierlamm et al.

    The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas

    Blood

    (1999)
  • T.G. Willis et al.

    Bcl10 is involved in t(1;14)(p22;q32) of MALT B-cell lymphoma and mutated in multiple tumor types

    Cell

    (1999)
  • H. Liu et al.

    T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10

    Blood

    (2001)
  • E.D. Remstein et al.

    Incidence and subtype specificity of API2—MALT1 fusion translocations in extranodal, nodal, and splenic marginal zone lymphomas

    American Journal of Pathology

    (2000)
  • M. Baens et al.

    The product of the t(11;18), an API2-MLT fusion, marks nearly half of gastric MALT type lymphomas without large cell proliferation

    American Journal of Pathology

    (2000)
  • M. Motegi et al.

    API2MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products

    American Journal of Pathology

    (2000)
  • H. Ye et al.

    Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma

    Blood

    (2003)
  • H. Liu et al.

    T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication

    Gastroenterology

    (2002)
  • P. Starostik et al.

    Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathogenetic pathways

    Blood

    (2002)
  • P.C. Lucas et al.

    Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-kappaB signaling pathway

    Journal of Biological Chemistry

    (2001)
  • L.M. McAllister-Lucas et al.

    Bimp1, a MAGUK family member linking PKC activation to Bcl10-mediated NF-κB induction

    Journal of Biological Chemistry

    (2001)
  • J. Ruland et al.

    Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure

    Cell

    (2001)
  • J. Bertin et al.

    CARD9 is a novel caspase recruitment domain-containing protein that interacts with BCL10/CLAP and activates NF-kappaB

    Journal of Biological Chemistry

    (2000)
  • L. Wang et al.

    Card10 is a novel caspase recruitment domain/membrane-associated guanylate kinase family member that interacts with BCL10 and activates NF-kappaB

    Journal of Biological Chemistry

    (2001)
  • J. Bertin et al.

    CARD11 and CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-kappaB

    Journal of Biological Chemistry

    (2001)
  • L. Bouchier-Hayes et al.

    CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-kappaB activation pathways

    Journal of Biological Chemistry

    (2001)
  • H. Ye et al.

    BCL10 expression in normal and neoplastic lymphoid tissue: nuclear localization in MALT lymphoma

    American Journal of Pathology

    (2000)
  • T. Koseki et al.

    CIPER, a novel NF kappaB-activating protein containing a caspase recruitment domain with homology to Herpes virus-2 protein E10

    Journal of Biological Chemistry

    (1999)
  • Cited by (0)

    View full text